Toyokawa Hideyoshi, Nakao Atsunori, Bailey Robert J, Nalesnik Michael A, Kaizu Takashi, Lemoine Jerome L, Ikeda Atsushi, Tomiyama Koji, Papworth Glenn D, Huang Leaf, Demetris Anthony J, Starzl Thomas E, Murase Noriko
Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA.
Liver Transpl. 2008 Mar;14(3):346-57. doi: 10.1002/lt.21378.
The interaction of donor passenger leukocytes and host leukocytes in recipient secondary lymphoid tissues during the early posttransplantation period is crucial in directing host immune reactions toward allograft rejection or acceptance. Responsible T cell clones could be activated through the direct and indirect pathways of allorecognition. We examined the role of the indirect pathway in liver transplantation (LT) tolerance by depleting host antigen-presenting cells (APC) with phagocytic activity [e.g., cluster domain (CD)68+/CD163+ macrophages, CD11c+ dendritic cells (DC)] using liposome-encapsulating clodronate (LP-CL). After Lewis rat cell or liver graft transplantation, Brown Norway (BN) rat recipients pretreated with LP-CL showed a significantly reduced type 1 helper T cell cytokine up-regulation than control-LP-treated recipients. In the LT model, LP-CL treatment and host APC depletion abrogated hepatic tolerance; Lewis liver grafts in LP-CL-treated-BN recipients developed mild allograft rejection, failed to maintain donor major histocompatibility complex (MHC) class II+ leukocytes, and developed chronic rejection in challenged donor heart allografts, while control-LP-treated BN recipients maintained tolerance status and donor MHC class II+ hepatic leukocytes. Furthermore, in the BN to Lewis LT model, LP-CL recipient treatment abrogated spontaneous hepatic allograft acceptance, and graft survival rate was reduced to 43% from 100% in the control-LP group. In conclusion, the study suggests that host cells with phagocytic activity could play significant roles in developing LT tolerance.
移植后早期,供体过客白细胞与受体二级淋巴组织中的宿主白细胞之间的相互作用对于引导宿主免疫反应朝向同种异体移植排斥或接受至关重要。负责的T细胞克隆可通过同种异体识别的直接和间接途径被激活。我们通过使用包裹氯膦酸盐的脂质体(LP-CL)消耗具有吞噬活性的宿主抗原呈递细胞(APC)[例如,簇结构域(CD)68+/CD163+巨噬细胞、CD11c+树突状细胞(DC)],研究了间接途径在肝移植(LT)耐受中的作用。在Lewis大鼠细胞或肝移植后,用LP-CL预处理的Brown Norway(BN)大鼠受体与对照LP处理的受体相比,1型辅助性T细胞细胞因子上调明显减少。在LT模型中,LP-CL处理和宿主APC消耗消除了肝耐受;LP-CL处理的BN受体中的Lewis肝移植发生轻度同种异体移植排斥,未能维持供体主要组织相容性复合体(MHC)II类+白细胞,并且在受挑战的供体心脏同种异体移植中发生慢性排斥,而对照LP处理的BN受体维持耐受状态和供体MHC II类+肝白细胞。此外,在BN到Lewis的LT模型中,LP-CL受体处理消除了自发的肝同种异体移植接受,移植存活率从对照LP组的100%降至43%。总之,该研究表明具有吞噬活性的宿主细胞在LT耐受的形成中可能起重要作用。